BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
10/3/22 Clovis Oncology (CLVS) Rubraca for Prostate Cancer Subscribers Only Subscribers Only Subscribers Only
10/3/22 Clene (CLNN) CNM-Au8 for Amyotrophic Lateral Sclerosis (ALS) Subscribers Only Subscribers Only Subscribers Only
9/30/22 Alnylam (ALNY) Onpattro for Transthyretin Amyloid Cardiomyopathy (ATTR-CM, Wild Type Or Hereditary) Subscribers Only Subscribers Only Subscribers Only
9/30/22 Intercept Pharmaceuticals (ICPT) Ocaliva for Non-Alcoholic Steatohepatitis (NASH) Subscribers Only Subscribers Only Subscribers Only
9/30/22 Zealand Pharma (ZEAL) Glepaglutide for Short Bowel Syndrome (SBS) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
10/05/22 Subscribers Only Subscribers Only Trial Data - Final Results
10/05/22 Subscribers Only Subscribers Only Trial Data - Final Results
10/05/22 Subscribers Only Subscribers Only Trial Data - Updated Results
10/05/22 Subscribers Only Subscribers Only Trial Announcement - Initiation
10/05/22 Subscribers Only Subscribers Only Trial Announcement - Other
Back to the top Back to the top